TOKYO - A government panel on Wednesday approved coverage of a new therapy to treat leukemia and other hematologic cancers, which currently costs 33.49 million yen ($305,000), by national health insurance, a move that would significantly ease the burden on patients.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
